Results 271 to 280 of about 3,072,312 (306)
Some of the next articles are maybe not open access.
Autoantibodies in interstitial lung diseases
Pathology, 2019The role of autoantibody testing for patients with interstitial lung disease is an evolving area. Recent guidelines recommend routine anti-nuclear antibodies, rheumatoid factor, and anti-citrullinated cyclic peptide antibody testing for patients undergoing diagnostic evaluation for interstitial lung disease, with further autoantibody testing reserved ...
Stevenson, B.R. +7 more
openaire +2 more sources
Autoimmunity and interstitial lung disease
Current Opinion in Pulmonary Medicine, 2005The pathogenesis of idiopathic pulmonary fibrosis as well as that of several other interstitial lung diseases is poorly understood. The role of autoimmunity in interstitial lung diseases associated with connective tissue disorders such as systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis as well as the vasculitides is well ...
Surinder K, Jindal, Ritesh, Agarwal
openaire +2 more sources
Rheumatoid interstitial lung disease
British Journal of Diseases of the Chest, 1965Summary A series of 8 patients with rheumatoid arthritis and diffuse interstitial lung disease has been described. In all but one the joint symptoms preceded the pulmonary changes. There was no correlation between the occurrence of pulmonary changes and the duration or severity of the joint condition, nor were these related to the level of ...
B H, Stack, I W, Grant
openaire +2 more sources
An update on interstitial lung disease
British Journal of Hospital Medicine, 2021Interstitial lung diseases are a complex group of conditions that cause inflammation and scarring of the lung interstitium. This article discusses the diagnosis and management of common interstitial lung diseases including idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, connective tissue disease associated-interstitial lung disease ...
D, Mudawi +4 more
openaire +2 more sources
Lung transplantation for interstitial lung diseases
Current Opinion in Pulmonary Medicine, 2014An overview over the role of lung transplantation in interstitial lung diseases will be given.Lung transplantation is an established therapy option for patients with various end-stage lung diseases. Currently, the worldwide procedural frequency is about 3600 per year.
openaire +2 more sources
Sleep and interstitial lung disease
Current Opinion in Pulmonary Medicine, 2019There is an increasing recognition of the impact of sleep and sleep disorders on respiratory disease. Recent years have seen a new focus on the relationship between sleep and outcomes in patients interstitial lung disease (ILD).Recent studies suggest a high prevalence of sleep issues in ILD cohorts, which seem to have a meaningful negative impact on ...
Katherine J, Myall +2 more
openaire +2 more sources
Lung Transplantation for Interstitial Lung Disease
Clinics in Chest Medicine, 2012For selected parenchymal lung disease patients who fail to respond to medical therapy and demonstrate declines in function that place them at increased risk for mortality, lung transplantation should be considered. Lung transplantation remains a complex medical intervention that requires a dedicated recipient and medical team.
openaire +2 more sources
Interstitial lung disease in infancy
The Indian Journal of Pediatrics, 2007To describe the clinical profile of interstitial lung disease in infancy.A retrospective analysis of cases diagnosed to have ILD was carried out in Kanchi Kamakoti CHILDS Trust hospital over a period of 2 yr. Infants aged 1 month to 1 yr of age were included if they had (1) respiratory symptoms (Cough, tachypnea or crepitations) for at least 1 month (2)
S, Balasubramanian +4 more
openaire +2 more sources
Interstitial lung disease in children
Current Opinion in Pediatrics, 2011In this review, we discuss the recent advances in our understanding of the cause, pathogenesis, presentation, diagnosis, treatment, and prognosis of interstitial lung disease (ILD) in children.The classification of ILD syndromes in children greater than 2 years of age is based largely on adult classification schemes.
Shailendra, Das +2 more
openaire +2 more sources
Biomarkers in Interstitial lung diseases
Paediatric Respiratory Reviews, 2015Interstitial lung diseases (ILD)s represent a heterogeneous group of rare respiratory disorders, mostly chronic and associated with high morbidity and mortality. They are complex diseases that remain, in children, largely underdiagnosed and difficult to manage. Therefore, identification of biomarkers, which could be used for ILD diagnosis, measurements
Nathan, Nadia +3 more
openaire +2 more sources

